Balyasny Asset Management’s AbCellera Biologics ABCL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-404,405
Closed -$2.03M 3031
2025
Q3
$2.03M Buy
404,405
+369,493
+1,058% +$1.63M ﹤0.01% 1782
2025
Q2
$120K Sell
34,912
-46,171
-57% -$115K ﹤0.01% 2673
2025
Q1
$181K Buy
81,083
+67,562
+500% +$194K ﹤0.01% 2607
2024
Q4
$39.6K Buy
+13,521
New +$37.7K ﹤0.01% 2644
2024
Q3
Sell
-34,794
Closed -$103K 2682
2024
Q2
$103K Sell
34,794
-23,716
-41% -$89.7K ﹤0.01% 2401
2024
Q1
$265K Buy
58,510
+43,657
+294% +$223K ﹤0.01% 2306
2023
Q4
$84.8K Buy
+14,853
New +$68.8K ﹤0.01% 2391
2023
Q3
Sell
-1,134,269
Closed -$7.33M 2199
2023
Q2
$7.33M Buy
+1,134,269
New +$7.74M 0.02% 912
2023
Q1
Sell
-153,025
Closed -$1.55M 2574
2022
Q4
$1.55M Buy
153,025
+102,193
+201% +$1.18M 0.01% 1510
2022
Q3
$503K Buy
+50,832
New +$558K ﹤0.01% 2036
2022
Q2
Sell
-62,339
Closed -$608K 2692
2022
Q1
$608K Buy
+62,339
New +$590K ﹤0.01% 1771

Other funds holding ABCL